SynAct Pharma, a Swedish listed biotechnology company has acquired all shares of TXP Pharma, a privately owned Swiss biotech company, researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. Through this
Tags :Alain P. Röthlisberger
BGPartner has advised a leading global provider of EAP (“employee assistance programme”) services on the successful acquisition of a European EAP provider and its subsidiaries. The transaction will allow the Swiss-based company to continue to
BGPartner Attorneys-at-law announced the opening of their Middle East Desk. The new addition will provide services to Swiss companies intending to invest in the Middle East (incl. Saudi Arabia) as well as gulf region corporations
Bader Gnehm & Partner has appointed Alain P. Röthlisberger (pictured) as of counsel. He focuses on contract law, commercial and company law, mergers and acquisitions, joint ventures, restructuring company successions as well as private
